person · Reporting owner

Liles Scott

Disclosed activity across 1 company

Tapewire entity: 52361
SEC CIK: 0002016253

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Covista Inc.CVSA · Entity 3964	President, Medical and Vet	April 15, 2026	April 16, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Covista Inc.

Report date April 15, 2026 · Filed April 16, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,103	Reported balance After 2026-04-15 transaction · row 1 1 source row Row 1 · 2026-04-15 · Tax withholding · Disposed 448 · Balance 13,103 F1: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 15, 2026 Filed Apr 16, 2026 20:15 UTC	Covista Inc. CVSA · Entity 3964	Tax withholdingCommon Stock	448	$112.49	$50,395.52	Disclosure SEC source: 0000730464-26-000016 · form4.xml · nonDerivative · entry 1 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,103 F1 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. Read SEC document
November 13, 2025 Filed Nov 14, 2025 21:21 UTC	Covista Inc. ATGE · Entity 3964	Tax withholdingCommon Stock	407	$96.26	$39,177.82	Disclosure SEC source: 0000730464-25-000050 · form4.xml · nonDerivative · entry 2 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,551 F2 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:21 UTC	Covista Inc. ATGE · Entity 3964	GrantCommon Stock	2,613	$96.86	$253,095.18	Disclosure SEC source: 0000730464-25-000050 · form4.xml · nonDerivative · entry 1 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,958 F1 · shares: Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 12, 2026. Read SEC document
August 23, 2025 Filed Aug 27, 2025 21:43 UTC	Covista Inc. ATGE · Entity 3964	Tax withholdingCommon Stock	2,784	$134.88	$375,505.92	Disclosure SEC source: 0000730464-25-000020 · form4.xml · nonDerivative · entry 2 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,345 F2 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of the GwP performance stock units. Read SEC document
August 23, 2025 Filed Aug 27, 2025 21:43 UTC	Covista Inc. ATGE · Entity 3964	GrantCommon Stock	6,844	$134.88	$923,118.72	Disclosure SEC source: 0000730464-25-000020 · form4.xml · nonDerivative · entry 1 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,129 F1 · shares: Common stock issued in payout of Growth with Purpose ("GwP") performance stock units awarded on April 15, 2024. Read SEC document
April 15, 2025 Filed Apr 16, 2025 20:24 UTC	Covista Inc. ATGE · Entity 3964	Tax withholdingCommon Stock	458	$106.36	$48,712.88	Disclosure SEC source: 0001127602-25-012127 · form4.xml · nonDerivative · entry 1 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,285 F1 · shares: Represents the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. Read SEC document
November 13, 2024 Filed Nov 15, 2024 21:15 UTC	Covista Inc. ATGE · Entity 3964	GrantCommon Stock	2,990	$89.85	$268,651.50	Disclosure SEC source: 0001127602-24-027397 · form4.xml · nonDerivative · entry 1 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,743 F1 · shares: Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on November 13, 2025. Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:11 UTC	Covista Inc. ATGE · Entity 3964	GrantCommon Stock	3,290	$45.59	$149,991.10	Disclosure SEC source: 0001127602-24-013098 · form4.xml · nonDerivative · entry 1 Liles Scott · CIK 0002016253 · President, Medical and Vet 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,753 F1 · shares: Consists of restricted stock units which convert into a share of common stock on a one-for-one basis. The restricted stock units vest in three equal installments beginning on April 15, 2025. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.